L J Fallowfield - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L J Fallowfield

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012

Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.

Lancet (London, England)|February 20, 2007

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialR C Coombes, L S Kilburn, C F Snowdon, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012

Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.

Lancet (London, England)|February 20, 2007

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialR C Coombes, L S Kilburn, C F Snowdon, et al.

Pageof 6